BACS™ Microbubbles: The Solution to Better Cell Separation

Georgi Makin
21 December 2022
SHARE NOW
ATW
Cell Therapy
Partnering
Raw Materials
In this interview, Brandon McNaughton, CEO and Co-Founder of Akadeum Life Sciences, explains the story of innovation for the application of microbubbles in cell therapy manufacturing, and the impact innovation can have on the future of healthcare.
Through explaining the story behind Akadeum and the application of innovative technologies, Brandon discusses the process of overcoming limitations and challenges associated with downstream cell therapy manufacturing.
Brandon goes on to discuss the process of deployment through collaboration, before explaining what it is companies like Akadeum look for in a partner, and what to look out from Akadeum over the next few months.
If you are joining us at Advanced Therapies Week 2023, make sure to visit Akadeum as the team previews their new automated instrument! Not yet registered? Get your tickets here >>
This interview has been produced in partnership with Akadeum Life Sciences, ahead of Advanced Therapies Week 2023.
![]() |
![]() |
More like this
20 Years of Advanced Therapies with David McCall: a Retrospective on Phacilitate’s Founding and Evolution of the Industry
Lee Buckler, SVP Advanced Therapies, Blood Centers of America, Advanced Therapies Network, reflects on two decades of working within the advanced therapies industry as Phacilitate celebrates 20 years of operating in the field.
4 December 2023
Oxford Biomedica Acquires ABL Europe from Institut Mérieux
Oxford Biomedica Acquires ABL Europe from Institut Mérieux
6 December 2023
Texas Children’s Hospital First to Deliver a Novel Gene Therapy for Rett Syndrome
Two female pediatric patients with Rett syndrome were the first children worldwide to receive the promising treatment with Neurogene’s lead gene therapy product.
5 December 2023